Variant report
Variant | nsv818231 |
---|---|
Chromosome Location | chr4:46555042-46589847 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:46444130..46446100-chr4:46557651..46559731,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551800352 | chr4:46556224-46556225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147769776 | chr4:46556233-46556234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570036256 | chr4:46556255-46556256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561578442 | chr4:46556264-46556265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10517164 | chr4:46556265-46556266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs139494725 | chr4:46556350-46556351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184539053 | chr4:46556371-46556372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114266314 | chr4:46556372-46556373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149951945 | chr4:46556375-46556376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551359876 | chr4:46556395-46556396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575714233 | chr4:46556457-46556458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376288899 | chr4:46556466-46556467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374584115 | chr4:46556534-46556535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535290889 | chr4:46556550-46556551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189293771 | chr4:46556592-46556593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs193114259 | chr4:46556648-46556649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568262098 | chr4:46556747-46556748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184594286 | chr4:46556780-46556781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201159958 | chr4:46556782-46556783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189236717 | chr4:46556808-46556809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539758970 | chr4:46556855-46556856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78168232 | chr4:46556864-46556865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575990678 | chr4:46556937-46556938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543153942 | chr4:46556969-46556970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4576046 | chr4:46557025-46557026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs573812613 | chr4:46557067-46557068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181643215 | chr4:46557097-46557098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565846704 | chr4:46557124-46557125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559612197 | chr4:46557132-46557133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12508971 | chr4:46557146-46557147 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs545299451 | chr4:46557179-46557180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367948336 | chr4:46557213-46557214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574755439 | chr4:46557214-46557215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75982034 | chr4:46557229-46557230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs59415827 | chr4:46557232-46557233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557354683 | chr4:46557260-46557261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530831289 | chr4:46557261-46557262 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549948561 | chr4:46557266-46557267 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561732903 | chr4:46557291-46557292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114375870 | chr4:46557441-46557442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs16859477 | chr4:46557475-46557476 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs565942602 | chr4:46557499-46557500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34016189 | chr4:46557531-46557532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112613785 | chr4:46557543-46557544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35084043 | chr4:46557568-46557569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184295836 | chr4:46557602-46557603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370782798 | chr4:46557638-46557639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555428704 | chr4:46557641-46557642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573653979 | chr4:46557655-46557656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534725249 | chr4:46557706-46557707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:46556200-46557400 | Enhancers | Fetal Brain Male | brain |
2 | chr4:46556600-46557200 | Enhancers | Fetal Brain Female | brain |
3 | chr4:46557200-46557600 | Weak transcription | Fetal Brain Female | brain |
4 | chr4:46557400-46557800 | Weak transcription | Fetal Brain Male | brain |
5 | chr4:46557600-46558000 | Enhancers | Fetal Brain Female | brain |
6 | chr4:46557800-46558000 | Enhancers | Fetal Brain Male | brain |
7 | chr4:46558000-46561000 | Weak transcription | Fetal Brain Male | brain |
8 | chr4:46559000-46559800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr4:46559000-46560000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:46561000-46561200 | Enhancers | Fetal Brain Male | brain |
11 | chr4:46561200-46561600 | Weak transcription | Fetal Brain Male | brain |
12 | chr4:46561600-46562000 | Enhancers | Fetal Brain Male | brain |
13 | chr4:46587600-46588800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr4:46588400-46589000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr4:46588400-46589600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr4:46588600-46589000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr4:46588600-46589000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |